Chronic urticaria treatment challenges in children
2024

Chronic Urticaria Treatment Challenges in Children

Sample size: 52 publication Evidence: moderate

Author Information

Author(s): Ensina Luis Felipe, Brandão Larissa Silva, Melo Ana Caroline Dela Bianca, Antila Martti, Ben-Shoshan Moshe, Solé Dirceu

Primary Institution: Universidade Federal de São Paulo, São Paulo, SP, Brazil.

Hypothesis

This paper aims to review the efficacy and safety of current chronic urticaria (CU) treatment in children and the existing patient-reported outcome measures (PROMs) used in this age group.

Conclusion

The existing data indicate that these drugs are safe and effective for treatment when dose adjustments are made.

Supporting Evidence

  • The effectiveness of high doses of antihistamines in children has been demonstrated with control rates ranging from 35% to 92%.
  • Omalizumab is approved for children over 12 years of age as a second step in the treatment algorithm.
  • Some data show complete control of symptoms in more than 80% of pediatric cases with no adverse effects.
  • When monitored closely, cyclosporine showed a good response rate in pediatric CU with few adverse events.
  • PROMs validated for this age can be helpful in clinical decisions.

Takeaway

This study looks at how to treat a skin problem called chronic urticaria in kids, showing that some medicines can help a lot when given in the right amounts.

Methodology

The authors performed a non-systematic review of published articles in English, Spanish, and Portuguese in the PubMed database in the last decade.

Potential Biases

Potential conflicts of interest were noted for some authors due to funding and consultancy roles.

Limitations

The study highlights the need for more collaborative studies to generate stronger evidence.

Participant Demographics

Children with chronic urticaria, with a median age of 9.5 years.

Digital Object Identifier (DOI)

10.1590/1984-0462/2025/43/2024107

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication